These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19907888)

  • 1. Managing vascular risk in hypertension with a focus on microalbuminuria: attitude and practices.
    Wu AY; Low LP
    Singapore Med J; 2009 Oct; 50(10):976-81. PubMed ID: 19907888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microalbuminuria prevalence study in hypertensive patients with type 2 diabetes mellitus in Singapore.
    Wu AY; Tan CB; Eng PH; Tan KT; Lim SC; Tan EK
    Singapore Med J; 2006 Apr; 47(4):315-20. PubMed ID: 16572244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of microalbuminuria in non-diabetic hypertensive patients attended by Portuguese GPs.
    Polónia J; Carmona J; Mendes E; Pisco L
    Rev Port Cardiol; 2007 Jun; 26(6):637-44. PubMed ID: 17849947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dental screening and referral of young children by pediatric primary care providers.
    dela Cruz GG; Rozier RG; Slade G
    Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twelve shifting paradigms in diabetic renal disease and hypertension.
    Mogensen CE
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microalbuminuria in essential hypertension.
    Crippa G
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S74-7. PubMed ID: 11986900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microalbuminuria and cardiovascular disease.
    Weir MR
    Clin J Am Soc Nephrol; 2007 May; 2(3):581-90. PubMed ID: 17699466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minor abnormalities of renal function: a situation requiring integrated management of cardiovascular risk.
    Segura J; Ruilope LM
    Fundam Clin Pharmacol; 2005 Aug; 19(4):429-37. PubMed ID: 16011729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psychosocial consequences of screening for microalbuminuria and for some other risk factors].
    Tijmstra T; Spijkers W; Broer J; Janssen WM; de Jong PE
    Ned Tijdschr Geneeskd; 2000 Dec; 144(51):2460-4. PubMed ID: 11151656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetes, hypertension and microalbuminuria in primary care].
    Bramlage P; Wittchen HU; Pittrow D; Dikow R; Kirch W; Lehnert H; Ritz E
    Fortschr Med Orig; 2003 Feb; 121 Suppl 1():33-8. PubMed ID: 14732948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Awareness and misconception of hypertension in Canada: results of a national survey.
    Petrella RJ; Campbell NR
    Can J Cardiol; 2005 May; 21(7):589-93. PubMed ID: 15940357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microalbuminuria in treated hypertensives: only a mirror image of cardiovascular risk? The HUNT Study, Norway.
    Kvenild K; Romundstad S; Midthjell K; Krüger O; Hallan H; Holmen J
    Scand J Prim Health Care; 2006 Sep; 24(3):145-53. PubMed ID: 16923623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
    Donnelly R; Yeung JM; Manning G
    J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of subclinical organ damage for risk assessment and treatment in the hypertensive patient: role of microalbuminuria.
    Pontremoli R; Leoncini G; Viazzi F; Ratto E; Vaccaro V; Falqui V; Parodi A; Conti N; Tomolillo C; Deferrari G
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S112-4. PubMed ID: 16565232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension management in primary care: standard care and attitude towards a disease management model.
    Wassenberg MW; Willemsen JM; Gaillard CA; Braam B
    Neth J Med; 2004 Nov; 62(10):375-82. PubMed ID: 15683092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microalbuminuria and cardiovascular risk.
    Karalliedde J; Viberti G
    Am J Hypertens; 2004 Oct; 17(10):986-93. PubMed ID: 15485765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microalbuminuria: do we need a new threshold?
    Zamora CR; Cubeddu LX
    J Hum Hypertens; 2009 Feb; 23(2):146-9. PubMed ID: 18784737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microalbuminuria and hypertension.
    Reboldi G; Gentile G; Angeli F; Verdecchia P
    Minerva Med; 2005 Aug; 96(4):261-75. PubMed ID: 16179893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global risk stratification in primary hypertension: the role of the kidney.
    Leoncini G; Ratto E; Viazzi F; Conti N; Falqui V; Parodi A; Tomolillo C; Deferrari G; Pontremoli R
    J Hypertens; 2008 Mar; 26(3):427-32. PubMed ID: 18300851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge and acceptance of hypertension guidelines in clinical practice: experience from Slovenia.
    Petek Ster M; Kersnik J
    Wien Klin Wochenschr; 2005 Aug; 117(15-16):534-40. PubMed ID: 16160803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.